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INTRODUCTION:
Factor V Leiden is the most common form of inherited thrombophilic syndrome, affecting five per cent of Caucasian people. Patients who are homozygous have an 80-fold relative risk of developing abnormal blood clots. Patients who are heterozygous, which is much more common, have a relative risk of three to eight.
1,2 While increased rates of venous thromboembolic complications have been regularly reported in factor V Leiden patients, little is known regarding their relative risk of microvascular complications or flap failure in free-flap surgery. The primary aim of this study was to evaluate the statistical and clinical significance of data in the extant literature on this subject.
METHODS:
Our study has three parts. First, we conducted a systematic (PRISMA) review on outcomes in factor V Leiden patients who had undergone free-flap surgery. Second, we assessed the current state of the literature on the pathophysiology of microvascular or intra-anastomotic thrombosis in patients with factor V Leiden. Third, we evaluated potential screening strategies for this patient population.
RESULTS:
Only nine studies, with a total of 22 patients and 24 free-flaps, fit the inclusion criteria for our systematic literature review. The extant literature suggests a trend towards increased flap failure rates in factor V Leiden patients, even in those who are heterozygous. However, the majority of studies were case series and therefore at high risk of publication bias. Moreover, the total number of patients was too small to be of statistical or clinical significance.
Literature on the pathophysiology of microvascular, as opposed to macrovascular, thrombosis in this patient population was found to be similarly scant. Various opinions exist regarding the role and the extent of pre-operative screening strategies for thrombophilias prior to free-flap surgery. However, specific screening protocols are yet to be evaluated for their impact on surgical outcomes, cost and quality of life.
CONCLUSION:
The current state of the literature on outcomes for free-flap reconstruction in factor V Leiden patients is inconclusive. Larger scale case-control studies are recommended. Knowledge on the pathophysiology of microvascular thrombosis in thrombophilic patients is also lacking. Given the significant economic and psychological costs associated with failed free-flap reconstructions, we advocate the use of a non-invasive screening protocol that involves preoperative collaboration with hematologists for theoretically at-risk patient populations.
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1. Lee A. Factor V Leiden. Nursing. 2014; 44 (6) We developed a novel technique condensing these steps into one closed-loop system. In this innovative method 3,4 we used a continuous flow pump to reinfuse fat to the breast. Del Vecchio also recently showed safety and efficiency with this method.
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METHODS:
We conducted a retrospective cohort review of patients receiving AFG for breast contouring either by the syringe or closed-loop method by a single surgeon. Time to infuse fat, complications, and outcomes were analyzed. The cohort included 19 syringe AFG procedures (34 breasts) and 25 closed-loop procedures (41 breasts) between 2013 and 2018. Both short term (infection, explant) and long-term complications (granulomas, cysts, biopsy) were analyzed.
RESULTS:
Average infusion time was 15 minutes (4-30) for the closed-loop technique. Clinical follow-up times ranged from 28 to 161 weeks (mean=88) for syringe and 0 to 130 weeks (mean=32) for the closed-loop method. There were 2 major and 6 minor complications out of 34 breasts in the syringe method (5.5%, 16.6%, overall 23.5%) versus 1 major and 5 minor complications out of 41 breasts in the closed-loop method (2.4%, 12.1%, overall 14.6%) [p-value major=0.49, minor=0.58, overall=0.33]. Syringe PRS Global Open • 2018 complications included 2 granulomas and 1 cyst (8.8%) while the closed-loop complications included 2 granulomas (4.9%) [p-value=0.50 ]. Average total volume transferred was 262cc (60-850) for syringe, and 334cc (80-795) for closed-loop method. Infusion rate for the closed-loop method ranged from 100 to 250 mL/min, most consistently at 125 ml/min.
CONCLUSION:
The study suggests the closed-loop technique significantly decreases time of fat transfer to an average of 15 minutes, a trend towards decreased overall complications, though not statistically significant, and good subjective fat retention beyond 12 months. This suggests the closed-loop method is safe, effective, and significantly decreases operating time. We continue to collect patients in the closed-loop cohort and are also analyzing variation in adipocyte viability between the two methods.
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1 There have been multiple nail bed deformities described that require excision for diagnostic and therapeutic purposes.
To the best of our knowledge, there have been no cases in the literature describing nail bed reconstruction with an extracellular matrix graft after nail bed excision. However, the effectiveness of acellular micronized extracellular matrix for open fingertip injuries has been documented. The ACell MatriStem ® Wound Matrix is comprised of naturally-occurring porcine urinary bladder matrix. This material supplies extracellular matrix proteins, delivers growth factors and recruits differentiated cells into the wound site. In addition, it contains an intact basement membrane and collagen which acts as a scaffold for regeneration.
We present a series of 9 patients (5 males and 4 females, mean age: 36.3) from December 2015 to January 2017 who underwent nail bed excision in the setting of a nail bed lesion, after which extracellular MatriStem ® Wound Matrix (ACell Inc., Columbia, MD) was applied. All patients underwent total onychectomy and wide local excision (total excisional diameter ranging from 6 mm -14 mm). This was in the setting of longitudinal melanonychia (4), chronic myxoid cyst (1), split nail deformity (1), verruca vulgaris (1) and squamous cell carcinoma (2). Of note, upon histological examination, none of the patients had melanoma. There were 9 fingers treated. All patients in the series had a follow up appointment every three to four weeks and were followed until complete wound healing. After a period of six weeks, complete healing of the nail bed was achieved in all cases. Furthermore, nail bed deformities were not identified in any patients.
The use of an extracellular matrix graft after excisional biopsy of the nail bed prevents nail matrix scarring. This decreases the risk of postoperative nail dystrophy and also decreases the need for further reconstructive procedures, including nail bed grafting.
